(Q46334066)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18832429%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

MDMA

0 references

title

Ecstasy (MDMA) and high prevalence psychiatric symptomatology: somatic anxiety symptoms are associated with polydrug, not ecstasy, use (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18832429%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18832429%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Nicholas T Van Dam

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18832429%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

author name string

J Redman

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18832429%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

language of work or name

English

0 references

publication date

2 October 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18832429%20AND%20SRC:MED&resulttype=core&format=json

Journal of Psychopharmacology

15 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18832429%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

volume

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18832429%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18832429%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

page(s)

233-240

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18832429%20AND%20SRC:MED&resulttype=core&format=json

Self-reported ecstasy use: the impact of assessment method on dosage estimates in recreational users.

15 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0269881108097631

Ecstasy use and higher-level cognitive functions: weak effects of ecstasy after control for potential confounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108097631

The effects of stereotype threat on cognitive function in ecstasy users.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108097631

21 January 2018

The BDI of the beholder

1 reference

https://api.crossref.org/works/10.1177%2F0269881108097631

Methodological problems with ecstasy and the SCL-90.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108097631

Is MDMA ('Ecstasy') neurotoxic in humans? An overview of evidence and of methodological problems in research

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108097631

Empathy and aggression: two faces of ecstasy? A study of interpretative cognitive bias and mood change in ecstasy users

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108097631

Self-reported psychopathological symptoms in recreational ecstasy (MDMA) users are mainly associated with regular cannabis use: further evidence from a combined cross-sectional/longitudinal investigation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108097631

Characteristics of ecstasy users in Sãio Paulo, Brazil.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108097631

Major depression: the relative contribution of gender, MDMA, and cannabis use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108097631

An examination of next-day hangover effects after a 100 mg/100 ml dose of alcohol in heavy social drinkers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108097631

Auditory verbal learning in drug-free Ecstasy polydrug users.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108097631

Residual neuropsychological effects of illicit 3,4-methylenedioxymethamphetamine (MDMA) in individuals with minimal exposure to other drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108097631

The acute and sub-acute effects of 'ecstasy' (MDMA) on processing of facial expressions: preliminary findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108097631

Neurocognitive function in current and ex-users of ecstasy in comparison to both matched polydrug-using controls and drug-naïve controls.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108097631

Cognitive function and mood in MDMA/THC users, THC users and non-drug using controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108097631

Gender differences in the subjective effects of MDMA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108097631

The spectrum of behaviors influenced by serotonin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108097631

Former chronic methylenedioxymethamphetamine (MDMA or ecstasy) users report mild depressive symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108097631

Cognitive performance in (+/-) 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") users: a controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108097631

Chronic MDMA (ecstasy) use, cognition and mood.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108097631

Anxiety, depression, and behavioral symptoms of executive dysfunction in ecstasy users: contributions of polydrug use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108097631

Ecstasy (MDMA): are the psychological problems associated with its use reversed by prolonged abstinence?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108097631

Human psychopharmacology of Ecstasy (MDMA): a review of 15 years of empirical research

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108097631

Ecstasy/MDMA attributed problems reported by novice, moderate and heavy recreational users.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108097631

Cognitive performance in recreational users of MDMA of 'ecstasy': evidence for memory deficits

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108097631

The development and testing of the depression, anxiety, and positive outlook scale (DAPOS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108097631

Neuropsychological performance in long-term cannabis users

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108097631

The residual cognitive effects of heavy marijuana use in college students.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108097631

(+/-)3,4-Methylenedioxymethamphetamine ('Ecstasy')-induced serotonin neurotoxicity: studies in animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108097631

Relationship between ecstasy use and depression: a study controlling for poly-drug use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108097631

The impact of regular ecstasy use on memory function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108097631

The association of depression and anxiety with obesity and unhealthy behaviors among community-dwelling US adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108097631

Self-reported depressive symptomatology in community samples of polysubstance misusers who report Ecstasy use: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108097631

Self-reported psychopathology in polydrug users.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108097631

Polydrug use, cannabis, and psychosis-like symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108097631

Sub-acute effects of MDMA (+/-3,4-methylenedioxymethamphetamine, "ecstasy") on mood: evidence of gender differences

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108097631

Drug abuse as self-medication for depression: an empirical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108097631

The Beck Anxiety Inventory in a non-clinical sample

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108097631